IL6 and cancer: As IL-6 produced in cancer cells can freely diffuse across the cell membrane into the stroma (Miki et al, 2009), the loss of tumoral sIL-6R expression may reflect either decreased production of sIL-6R itself or increased consumption of sIL-6R by enhanced IL-6/sIL-6R affinity in the cancer stroma.